OPKO Health Total Current Assets 2010-2024 | OPK

OPKO Health total current assets from 2010 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
OPKO Health Annual Total Current Assets
(Millions of US $)
2023 $309
2022 $395
2021 $823
2020 $523
2019 $324
2018 $318
2017 $349
2016 $484
2015 $454
2014 $143
2013 $243
2012 $79
2011 $100
2010 $57
2009 $64
OPKO Health Quarterly Total Current Assets
(Millions of US $)
2024-06-30 $358
2024-03-31 $391
2023-12-31 $309
2023-09-30 $357
2023-06-30 $434
2023-03-31 $406
2022-12-31 $395
2022-09-30 $414
2022-06-30 $495
2022-03-31 $754
2021-12-31 $823
2021-09-30 $558
2021-06-30 $547
2021-03-31 $599
2020-12-31 $523
2020-09-30 $428
2020-06-30 $360
2020-03-31 $274
2019-12-31 $324
2019-09-30 $293
2019-06-30 $344
2019-03-31 $435
2018-12-31 $318
2018-09-30 $290
2018-06-30 $322
2018-03-31 $349
2017-12-31 $349
2017-09-30 $431
2017-06-30 $473
2017-03-31 $460
2016-12-31 $484
2016-09-30 $502
2016-06-30 $506
2016-03-31 $454
2015-12-31 $454
2015-09-30 $517
2015-06-30 $278
2015-03-31 $394
2014-12-31 $143
2014-09-30 $163
2014-06-30 $183
2014-03-31 $205
2013-12-31 $243
2013-09-30 $241
2013-06-30 $230
2013-03-31 $238
2012-12-31 $79
2012-09-30 $88
2012-06-30 $92
2012-03-31 $99
2011-12-31 $100
2011-09-30 $118
2011-06-30 $128
2011-03-31 $143
2010-12-31 $57
2010-09-30 $45
2010-06-30 $45
2010-03-31 $63
2009-12-31 $64
2009-09-30 $72
2009-06-30 $50
2009-03-31 $11
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.130B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $233.063B 27.94
Intuitive Surgical (ISRG) United States $171.313B 97.00
Alcon (ALC) Switzerland $47.672B 33.56
IQVIA Holdings (IQV) United States $44.239B 25.07
IDEXX Laboratories (IDXX) United States $42.083B 50.62
Edwards Lifesciences (EW) United States $40.680B 26.07
DexCom (DXCM) United States $27.834B 39.69
STERIS (STE) Ireland $23.508B 27.43
SONOVA HOLDING (SONVY) Switzerland $20.781B 0.00
Waters (WAT) United States $19.789B 29.50
Hologic (HOLX) United States $18.981B 20.64
Sysmex ADR (SSMXY) Japan $12.317B 38.62
Fresenius Medical Care AG KGaA (FMS) Germany $12.224B 13.70
Teleflex (TFX) United States $11.380B 17.69
Globus Medical (GMED) United States $9.423B 26.36
Penumbra (PEN) United States $7.597B 78.86
Glaukos (GKOS) United States $6.721B 0.00
Masimo (MASI) United States $6.081B 32.57
TransMedics (TMDX) United States $5.203B 222.80
PROCEPT BioRobotics (PRCT) United States $4.309B 0.00
Integer Holdings (ITGR) United States $4.304B 25.17
Tandem Diabetes Care (TNDM) United States $2.791B 0.00
LivaNova (LIVN) United Kingdom $2.773B 16.26
Veracyte (VCYT) United States $2.593B 160.76
Inari Medical (NARI) United States $2.586B 0.00
Elekta AB (EKTAY) Sweden $2.562B 20.88
Nihon Kohden (NHNKY) Japan $2.508B 15.61
RxSight (RXST) United States $2.003B 0.00
Integra LifeSciences Holdings (IART) United States $1.360B 6.19
Pulse Biosciences (PLSE) United States $1.163B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.112B 19.84
Artivion (AORT) United States $1.046B 96.04
Alphatec Holdings (ATEC) United States $0.864B 0.00
OrthoPediatrics (KIDS) United States $0.728B 0.00
Mesa Laboratories (MLAB) United States $0.682B 17.23
SiBone (SIBN) United States $0.654B 0.00
AxoGen (AXGN) United States $0.638B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.616B 0.00
IRadimed (IRMD) United States $0.614B 33.19
Paragon 28 (FNA) United States $0.581B 0.00
Pacific Biosciences Of California (PACB) United States $0.526B 0.00
Treace Medical Concepts (TMCI) United States $0.341B 0.00
Sight Sciences (SGHT) United States $0.330B 0.00
Tactile Systems Technology (TCMD) United States $0.327B 9.98
ClearPoint Neuro (CLPT) United States $0.322B 0.00
AngioDynamics (ANGO) United States $0.306B 0.00
Inogen (INGN) United States $0.253B 0.00
Delcath Systems (DCTH) United States $0.251B 0.00
Nevro (NVRO) United States $0.217B 0.00
NeuroPace (NPCE) United States $0.199B 0.00
Accuray (ARAY) United States $0.190B 0.00
CVRx (CVRX) United States $0.189B 0.00
Atossa Genetics (ATOS) United States $0.179B 0.00
Semler Scientific (SMLR) United States $0.173B 12.15
Alpha Tau Medical (DRTS) Israel $0.162B 0.00
Spectral Diagnostics (EDTXF) Canada $0.135B 0.00
908 Devices (MASS) United States $0.128B 0.00
KORU Medical Systems (KRMD) United States $0.122B 0.00
EDAP TMS S.A (EDAP) France $0.114B 0.00
Monogram Orthopaedics (MGRM) United States $0.103B 0.00
Sensus Healthcare (SRTS) United States $0.099B 14.81
Hyperfine (HYPR) United States $0.070B 0.00
EnVVeno Medical (NVNO) United States $0.068B 0.00
InspireMD (NSPR) Israel $0.066B 0.00
WORK Medical Technology Group (WOK) China $0.063B 0.00
Covalon Technologies (CVALF) Canada $0.062B 0.00
Envoy Medical (COCH) United States $0.061B 0.00
LENSAR (LNSR) United States $0.049B 0.00
Lucid Diagnostics (LUCD) United States $0.045B 0.00
T2 Biosystems (TTOO) United States $0.038B 0.00
Rapid Micro Biosystems (RPID) United States $0.036B 0.00
Precision Optics (POCI) United States $0.035B 0.00
Accelerate Diagnostics (AXDX) United States $0.035B 0.00
Vicarious Surgical (RBOT) United States $0.034B 0.00
Adagio Medical Holdings (ADGM) United States $0.032B 0.00
Neuronetics (STIM) United States $0.029B 0.00
Lifeward (LFWD) United States $0.028B 0.00
DarioHealth (DRIO) United States $0.027B 0.00
Ekso Bionics Holdings (EKSO) United States $0.022B 0.00
Pixie Dust Technologies (PXDT) Japan $0.022B 0.00
Spectral AI (MDAI) United States $0.021B 0.00
PAVmed (PAVM) United States $0.017B 0.00
NexGel (NXGL) United States $0.016B 0.00
Autonomix Medical (AMIX) United States $0.016B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
QT Imaging Holdings (QTI) United States $0.013B 0.00
Check-Cap (CHEK) Israel $0.010B 0.00
ReShape Lifesciences (RSLS) United States $0.005B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00